In mouse models of MCF7 breast cancer, treatment with ARV-471 in a dose as low as 3 mg/kg, p.o., daily, led to tumor regression together with > 90% of ER reduction in the tumor tissues. The gene discussed is ESR1; the disease is neoplasm.